Chinese Journal of Pharmaceuticals
|
2024, 55(8): 1143-1147
• Development and Production Quality Control of Gene Drugs •
Case Study of mRNA Vaccine Regulation——Based on the FDA Review of COVID-19 mRNA Vaccines
Full
Fen LIU, Yifei CHEN, Jianing YU
*
Affiliations
- Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203
Published: 2024-08-10
doi: 10.16522/j.cnki.cjph.2024.08.016
Outline
刘芬, 陈一飞, 俞佳宁.
mRNA疫苗监管案例分析——基于FDA对COVID-19 mRNA疫苗的审评.
中国医药工业杂志,
2024
, 55
(8)
: 1143
-1147
.
DOI: 10.16522/j.cnki.cjph.2024.08.016
Fen LIU, Yifei CHEN, Jianing YU.
Case Study of mRNA Vaccine Regulation——Based on the FDA Review of COVID-19 mRNA Vaccines[J].
Chinese Journal of Pharmaceuticals,
2024
, 55
(8)
: 1143
-1147
.
DOI: 10.16522/j.cnki.cjph.2024.08.016
Year 2024 volume 55 Issue 8
27
8
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2024.08.016
- Receive Date:2023-12-23
- Online Date:2026-11-18
- Published:2024-08-10